Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1 results about "Trelagliptin" patented technology

Trelagliptin (trade name Zafatek) is a pharmaceutical drug used for the treatment of type 2 diabetes (diabetes mellitus).

Preparation method for trelagliptin and salt thereof

InactiveCN105985316AReduce generationSimple separation and purification methodOrganic chemistryAcetic acidOrganic solvent
The invention discloses a preparation method for trelagliptin and a salt thereof. The preparation method comprises the following steps: a, subjecting a compound 3, Pd(OAc)2, ligand, K3PO4, 3-tertbutyloxycarbonyl-aminopiperidine, and an organic solvent to a reaction with stirring under the protection of nitrogen so as to obtain a reaction solution; b, carrying out separation and purification so as to obtain a compound 6; c, subjecting the compound 6, ethyl acetate and an ethyl acetate solution of HCl to a reaction with stirring and then carrying out separation and purification so as to obtain a solid; and d, dissolving the solid obtained in the step c in water, adjusting a pH value to 8 to 9 and then carrying out separation and purification so as to obtain a compound 4, i.e., trelagliptin. The preparation method provided by the invention reduces side reactions and production of impurity compounds; the method is simple and convenient in separating and purifying trelagliptin and has the advantages of short production period, high yield, high purity, low cost, etc.; and the yield of trelagliptin in the invention can reach 95% or above, and the preparation method is suitable for industrial production.
Owner:SICHUAN KELUN PHARMA RES INST CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products